First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors

  • Gerald Falchook
  • , Jeffrey Infante
  • , Hendrik Tobias Arkenau
  • , Manish R. Patel
  • , Emma Dean
  • , Erkut Borazanci
  • , Andrew Brenner
  • , Natalie Cook
  • , Juanita Lopez
  • , Shubham Pant
  • , Arthur Frankel
  • , Peter Schmid
  • , Kathleen Moore
  • , William McCulloch
  • , Katharine Grimmer
  • , Marie O'Farrell
  • , George Kemble
  • , Howard Burris

Research output: Contribution to journal › Article › peer-review

199 Scopus citations

Fingerprint

Dive into the research topics of 'First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science